About Us | Contact

Dr. Sandhya Khurana Investigator

Critical Care Medicine Strong Memorial Hospital NPI1588678874
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$3,785.20
from 19 payments in the last 6 years

Total Cash or Cash Equivalent

$1,092.60
from 3 payments in the last 6 years

Total In-kind Items & Services

$2,692.60
from 16 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
09/21/2021 General (Non-Research) In-kind items and services Food and Beverage $75.92 Details
Payment from GENZYME CORPORATION
Payment Record ID 843528387
07/22/2016 General (Non-Research) In-kind items and services Gift $60.00 Details
Payment from Resmed Corp
Payment Record ID 753367827
03/07/2019 General (Non-Research) In-kind items and services Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $501.03 Details
Payment from Boehringer Ingelheim International GmbH
Payment Record ID 703446285
05/08/2019 General (Non-Research) In-kind items and services Food and Beverage $99.13 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 688760867
03/29/2018 General (Non-Research) In-kind items and services Food and Beverage $110.84 Details
Payment from GlaxoSmithKline, LLC.
Payment Record ID 593781557
10/24/2018 General (Non-Research) In-kind items and services Food and Beverage $90.16 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 559642991
08/14/2017 Research In-kind items and services $50.88 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTICENTER, STRATIFIED ST
Payment Record ID 519647381
08/14/2017 Research In-kind items and services $27.67 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTICENTER, STRATIFIED ST
Payment Record ID 519647379
08/14/2017 Research In-kind items and services $509.76 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTICENTER, STRATIFIED ST
Payment Record ID 519647359
08/14/2017 Research In-kind items and services $55.25 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTICENTER, STRATIFIED ST
Payment Record ID 519647325
08/14/2017 Research In-kind items and services $32.85 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTICENTER, STRATIFIED ST
Payment Record ID 519647303
08/14/2017 Research In-kind items and services $220.64 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTICENTER, STRATIFIED ST
Payment Record ID 519647295
05/23/2017 General (Non-Research) In-kind items and services Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $538.58 Details
Payment from Boehringer Ingelheim Pharma GmbH & Co.KG
Payment Record ID 500638527
01/13/2017 General (Non-Research) In-kind items and services Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $239.33 Details
Payment from Boehringer Ingelheim Pharma GmbH & Co.KG
Payment Record ID 500637329
03/05/2017 General (Non-Research) In-kind items and services Food and Beverage $12.58 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 444864819
11/02/2016 Research Cash or cash equivalent $92.94 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study 205076 A Phase II, multicenter, randomized, double blind sponsor unblind , placebo controlled, parallel group trial to evaluate the efficacy and safety of sirukumab in subjects with severe, poorly controlled asthma
Payment Record ID 387054748
11/02/2016 Research Cash or cash equivalent $183.47 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study 205076 A Phase II, multicenter, randomized, double blind sponsor unblind , placebo controlled, parallel group trial to evaluate the efficacy and safety of sirukumab in subjects with severe, poorly controlled asthma
Payment Record ID 387054664
11/02/2016 Research Cash or cash equivalent $816.19 Details
Payment from GlaxoSmithKline, LLC.
Paymment Research Study 205076 A Phase II, multicenter, randomized, double blind sponsor unblind , placebo controlled, parallel group trial to evaluate the efficacy and safety of sirukumab in subjects with severe, poorly controlled asthma
Payment Record ID 387054464
10/24/2016 General (Non-Research) In-kind items and services Food and Beverage $67.98 Details
Payment from Boston Scientific Corporation
Payment Record ID 361914556
;